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Summary
Approximately 5–6.5% of adrenal incidentalomas are pheochromocytomas, and 8% of the patients with a pheo-
chromocytoma are completely asymptomatic. Marker-negative pheochromocytomas represent a small group of rare 
tumours, yet rarely reported in the current medical literature. In the current study presents a case of 49-year old 
patient with hypertension, caused by biochemically silent pheochromocytoma and the potential medical complica-
tions, which can be particularly dangerous in cases of misdiagnosed, non-functional tumours.
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Case report
49-year-old patient with paroxysmal hypertension 
complicated by grade I/II hypertensive retinopathy 
was admitted to Department of Hypertensiology due 
to episodes of high blood pressure (BP) accompanied 
by severe headache, sweating, pale skin of the face, 
and tremor. Three months prior to current hospita-
lization, patient had a CT scan of abdomen which 
revealed right adrenal tumour classified as inciden-
taloma. At the time of examination, BP was 130/ 
/87 mm Hg and heart rate 68/min. Physical examination 
showed a systolic murmur with maximal loudness on 
the left edge of the sternum. Standard electrocardi-
ography and heart ultrasonography were normal. 
Laboratory tests revealed mild normocytic anaemia 
and hypercholesterolemia. Plasma renin activity and 
aldosterone level (in the basal conditions and after 
administration of 2.0 L of saline) were normal. Simi-
larly, metanephrine excretion values in 24-hour urine 
collection, repeated four times, were within normal 
ranges. Baseline clinical and biochemical characte-
ristics are shown in Table I. In 24-hour Ambulatory 
Blood Pressure Monitoring (ABPM), mean BP was 
131/82 mm Hg (range from 104/65 mm Hg to 
198/106 mm Hg) (Figure 1). Angio-CT of the ab-
domen revealed a nodular mass in the right adrenal 
gland with density of 44/95/74 HU and the absolute 
washout rate of 41.2% which ruled out the diagnosis 
of adenoma (Figure 2). Metaiodobenzylguanidine 
scintigraphy (MIBG) showed area of excessive tracer 
accumulation in the right adrenal gland, suggesting 
pheochromocytoma (Figure 3). During hospitaliza-
tion, several acute episodes of hypertension associat-
ed with headache, pallor of skin, sweating, anxiety, 
and hyperglycaemia were observed.
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Figure 1. The result of 24-hour Ambulatory Blood Pressure Monitoring Figure 3. MIBG Scintigraphy
Table I. Baseline clinical and biochemical characteristics
Clinical parameters Value
Systolic blood pressure [mm Hg] 131
Diastolic blood pressure [mm Hg] 82
Mean arterial pressure [mm Hg] 98.3
Height [cm] 174
Weight [kg] 71
Body mass index [kg/m2] 23.4
Biochemical parameters
Plasma cortisol AT 8:00 AM [ug/dL] 12.9
Plasma cortisol after 1mg of Dexa-
methasone [ug/dL]
0.64
Plasma Androstenedione [ng/mL] 0.48
Plasma Aldosterone 63
Plasma Renin Activity 1.03
24-hour urine metanephrines 
[mg/24h]
48–58–48–94
Figure 2. CT scan (Courtesy of Professor Anna Walecka, PMU 2015)
Patient was referred to surgery unit with diagnosis 
of pheochromocytoma. Before surgical procedure, 
patient received a 2-week treatment with alpha and 
beta blockers, according to current recommenda-
tions and clinical guidelines [1]. During surgical re-
moval of right adrenal gland, hypertensive episode 
requiring administration of phentolamine occurred. 
Histopathological examination confirmed pheochro-
mocytoma. 
Discussion
Approximately 5–6.5% of adrenal incidentalomas 
are pheochromocytomas, and 8% of the patients 
with a pheochromocytoma are completely asymp-
tomatic and usually have a familial form [2]. The 
sensitivity of the 24-hour urinary metanephrines 
collection in the diagnosis of pheochromocytoma 
has been reported to 98% [3]. Marker-negative 
pheochromocytomas represent a  small group of 
rare tumours [4]. In spite of the fact that there 
is a  little information in the current literature 
on the prevalence of marker-negative pheochro-
mocytomas, the existence of these cases has been 
established [2, 5–8]. Vanderveen et al. examined 
a group of 20 patients with pheochromocytomas 
and paragangliomas, where two of them were 
biochemical negative [9]. Timmers et al. have re-
ported a biochemically silent abdominal paragan-
gliomas in 4 patients with a mutation in the succi-
nate dehydrogenase subunit B (SDHB) gene [10]. 
Literature data indicate a  relationship between 
the size of pheochromocytoma and its bioche-
mical activity and identify cases of clinically and 
biochemically asymptomatic tumours with sizes 
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less than 1 cm [11–13]. Several studies explored 
the associations between BMI and metanephrines 
levels, indicating a higher incidence of obesity in 
marker-negative patients with pheochromocyto-
ma [2].
In this case, the patient had a  larger tumour 
mass, typical clinical symptoms, BMI and the con-
centration of metanephrine in 24-hour urine col-
lection within the normal range. Thus, the diag-
nostic value of this test is not absolute. Literature 
suggests several possible reasons for these findings: 
the presence of a smaller piece of functional tissue, 
the release of a small amount of unmetabolized cat-
echolamines due to a rapid intratumoural turnover 
rate, episodically secreting tumours, silent stress-ac-
tivated tumours, and false negative results due to 
the high-temperature handling of the laboratory 
specimen and an ingestion of caffeine 24 hours 
prior to the testing [2].
Our patient suffered a  hypertensive episode 
during adrenalectomy. This case demonstrates the 
potential complications of surgical intervention, 
which can be particularly dangerous in cases of 
misdiagnosed, non-functional tumours, as demon-
strated by Heavner M. et al. [14].
In conclusion, among patients with adrenal inci-
dentalomas, biochemically negative pheochromocy-
tomas are rare, but not uncommon [14]. Episodic 
course of hypertension in patients with adrenal 
tumours, even with normal biochemical test results, 
should obligate to suspect the pheochromocytoma 
and expand the diagnostics accordingly.
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